Related references
Note: Only part of the references are listed.Selection-based discovery of macrocyclic peptides for the next generation therapeutics
Tomomi Morioka et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2015)
Artificial human Met agonists based on macrocycle scaffolds
Kenichiro Ito et al.
NATURE COMMUNICATIONS (2015)
Selection-Based Discovery of Druglike Macrocyclic Peptides
Toby Passioura et al.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 83 (2014)
Aptamer-based cell imaging reagents capable of fluorescence switching
Yun Kyung Jung et al.
CHEMICAL COMMUNICATIONS (2014)
A strain-promoted alkyne-azide cycloaddition (SPAAC) reaction of a novel EpCAM aptamer-fluorescent conjugate for imaging of cancer cells
Nithya Subramanian et al.
CHEMICAL COMMUNICATIONS (2014)
Shark Attack: High affinity binding proteins derived from shark vNAR domains by stepwise in vitro affinity maturation
Stefan Zielonka et al.
JOURNAL OF BIOTECHNOLOGY (2014)
EpCAM-Selective Elimination of Carcinoma Cells by a Novel MAP-Based Cytolytic Fusion Protein
Dmitrij Hristodorov et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Structural basis for gating mechanisms of a eukaryotic P-glycoprotein homolog
Atsushi Kodan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Selection of DNA Aptamers against Epithelial Cell Adhesion Molecule for Cancer Cell Imaging and Circulating Tumor Cell Capture
Yanling Song et al.
ANALYTICAL CHEMISTRY (2013)
Structural basis for the drug extrusion mechanism by a MATE multidrug transporter
Yoshiki Tanaka et al.
NATURE (2013)
In Vitro Selection of Anti-Akt2 Thioether-Macrocyclic Peptides Leading to Isoform-Selective Inhibitors
Yuuki Hayashi et al.
ACS CHEMICAL BIOLOGY (2012)
Discovery of Macrocyclic Peptides Armed with a Mechanism-Based Warhead: Isoform-Selective Inhibition of Human Deacetylase SIRT2
Jumpei Morimoto et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Epithelial cell adhesion molecule expression (CD326) in cancer: A short review
Carlo Patriarca et al.
CANCER TREATMENT REVIEWS (2012)
Selective thioether macrocyclization of peptides having the N-terminal 2-chloroacetyl group and competing two or three cysteine residues in translation
Kazuhiro Iwasaki et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2012)
Straightforward thiol-mediated protein labelling with DTPA: Synthesis of a highly active In-111-annexin A5-DTPA tracer
Harald Kratz et al.
EJNMMI RESEARCH (2012)
Natural Product-Like Macrocyclic N-Methyl-Peptide Inhibitors against a Ubiquitin Ligase Uncovered from a Ribosome-Expressed De Novo Library
Yusuke Yamagishi et al.
CHEMISTRY & BIOLOGY (2011)
A Novel Fusion Toxin Derived from an EpCAM-Specific Designed Ankyrin Repeat Protein Has Potent Antitumor Activity
Patricia Martin-Killias et al.
CLINICAL CANCER RESEARCH (2011)
DARPins Recognizing the Tumor-Associated Antigen EpCAM Selected by Phage and Ribosome Display and Engineered for Multivalency
Nikolas Stefan et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
Flexizymes for genetic code reprogramming
Yuki Goto et al.
NATURE PROTOCOLS (2011)
Catumaxomab Clinical development and future directions
Rolf Linke et al.
MABS (2010)
Antibodies targeting cancer stem cells A new paradigm in immunotherapy?
Mahendra P. Deonarain et al.
MABS (2009)
Nuclear signalling by tumour-associated antigen EpCAM
Dorothea Maetzel et al.
NATURE CELL BIOLOGY (2009)
Reprogramming the translation initiation for the synthesis of physiologically stable cyclic peptides
Yuki Goto et al.
ACS CHEMICAL BIOLOGY (2008)
Epithelial cell adhesion molecule - More than a carcinoma marker and adhesion molecule
Monika Trzpis et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
EpCAM an immunotherapeutic target for gastrointestinal malignancy: current experience and future challenges
M. A. Chaudry et al.
BRITISH JOURNAL OF CANCER (2007)
Chemosensitization of carcinoma cells using epithelial cell adhesion molecule-targeted liposomal antisense against bcl-2/bcl-xL
Sajid Hussain et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer
Gilbert Spizzo et al.
GYNECOLOGIC ONCOLOGY (2006)
Site-specific PEGylation of native disulfide bonds in therapeutic proteins
Sunil Shaunak et al.
NATURE CHEMICAL BIOLOGY (2006)
Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers
P Went et al.
BRITISH JOURNAL OF CANCER (2006)
The cell-cell adhesion molecule EpCAM interacts directly with the tight junction protein claudin-7
M Ladwein et al.
EXPERIMENTAL CELL RESEARCH (2005)
Expression of epithelial cell adhesion molecule (EpCam) in renal epithelial tumors
P Went et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy
WA Osta et al.
CANCER RESEARCH (2004)
High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer
G Spizzo et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation
M Münz et al.
ONCOGENE (2004)
Biological role of Ep-CAM in the physical interaction between epithelial cells and lymphocytes in intestinal epithelium
T Nochi et al.
CLINICAL IMMUNOLOGY (2004)
EpCAM - A new therapeutic target for an old cancer antigen
A Armstrong et al.
CANCER BIOLOGY & THERAPY (2003)
Ep-CAM transfection in thymic epithelial cell lines triggers the formation of dynamic actin-rich protrusions involved in the organization of epithelial cell layers
JC Guillemot et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2001)
Share Paper
